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AbstrAct
Objectives This study explored the reasons for patients’ 
non-adherence to cardiometabolic medications, and tested 
the acceptability of the interactive voice response (IVR) 
as a way to address these reasons, and support patients, 
between primary care consultations.
Design, method, participants and setting The study 
included face-to-face interviews with 19 patients with 
hypertension and/or type 2 diabetes mellitus, selected 
from primary care databases, and presumed to be non-
adherent. Thirteen of these patients pretested elements of 
the IVR intervention few months later, using a think-aloud 
protocol. Five practice nurses were interviewed. Data were 
analysed using multiperspective, and longitudinalthematic 
analysis.
results Negative beliefs about taking medications, the 
complexity of prescribed medication regimens, and the 
limited ability to cope with the underlying affective state, 
within challenging contexts, were mentioned as important 
reasons for non-adherence. Nurses reported time 
constraints to address each patient’s different reasons for 
non-adherence, and limited efficacy to support patients, 
between primary care consultations. Patients gave 
positive experiential feedback about the IVR messages 
as a way to support them take their medicines, and 
provided recommendations for intervention content and 
delivery mode. Specifically, they liked the voice delivering 
the messages and the voice recognition software. For 
intervention content, they preferred messages that were 
tailored, and included messages with ‘information about 
health consequences’, ‘action plans’, or simple reminders 
for performing the behaviour.
conclusions Patients with hypertension and/or type 
2 diabetes, and practice nurses, suggested messages 
tailored to each patient’s reasons for non-adherence. 
Participants recommended IVR as an acceptable platform 
to support adherence to cardiometabolic medications 
between primary care consultations. Future studies could 
usefully test the acceptability, and feasibility, of tailored 
IVR interventions to support medication adherence, as an 
adjunct to primary care.
IntrODuctIOn
Primary care consultations aim to advise and 
support patients in their decision to take the 
prescribed medications1; however, a substan-
tial proportion of patients cease, or do not 
take, their medications as prescribed, after 
leaving the consultation room.2 3 Non-ad-
herence to medications contributes to low 
treatment efficacy and increased National 
Health Service (NHS) costs,4 particularly for 
people who use healthcare services regularly, 
such as patients with either type 2 diabetes 
mellitus (T2DM), or hypertension, or those 
with both health conditions.2 4 5
Patients’ non-adherence is influenced by 
one, or both, intentional (INA) and non-inten-
tional (NINA) reasons.6 7 INA refers to those 
reasons that are under patients’ conscious 
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Research
strengths and limitations of this study
 ► Participants: patients presumed to be non-adherent 
to cardiometabolic medications, and nurses with 
experience in advising patients for medication 
taking, recruited by primary care practices within 
different levels of deprivation.
 ► Analysis: in-depth, multiperspective, thematic 
analysis of patients and nurses’ views on the 
reasons for non-adherence; current actions to 
address these reasons; and the acceptability of 
interactive voice response (IVR) delivery mode, and 
content, to support patients’ adherence between 
primary care consultations.
 ► Design: face-to-face interviews to explore reasons 
for non-adherence, and think-aloud protocol to 
explore the acceptability of the IVR.
 ► Applicability: consideration should be given when 
translating these results to different populations and 
settings.
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decisions to miss, or alter, medication regimens; whereas 
NINA refers to those reasons that are outside patients’ 
conscious consideration of their behaviour. Currently, 
we do not know the reasons for non-adherence, and how 
to effectively address them8; and practitioners’ time is 
limited and expensive. Both NICE (National Institute for 
Health and Care Excellence) guidelines1 and a report 
commissioned by the Department of Health,4 recom-
mend the development, and test, of novel interventions 
to actively involve patients in addressing non-adherence, 
not only during, but also between primary care consulta-
tions.
Interventions using existing telephone systems are 
promising platforms to support patients, as an adjunct to 
primary care.9 10 Our recent systematic review found that 
automated telephone-based interventions can double 
the odds to promote medication adherence, when added 
or compared to usual care.11 Such interventions enable 
behaviour change using automated, and interactive, 
voice response (IVR) messages. In the UK, adults use 
216.8 billion minutes in voice calls (142.8 billion min via 
mobile phones and 74 billion min via fixed lines) every 
year.12 13 Despite the major potential to reach a large 
number of patients, even in remote areas, and facilitate 
the delivery of low-cost medication adherence services,14 
the acceptability of such systems has not been tested in 
the UK primary care setting.
To address this gap, this study aimed to develop, and 
assess the acceptability of, elements of an IVR intervention 
to support adherence to cardiometabolic medications. To 
achieve this, the present study identified the reasons for 
patients’ non-adherence; the current actions to facilitate 
adherence; and obtained views and recommendations 
about an IVR intervention to influence these reasons and 
support adherence, as an adjunct to primary care consul-
tations.
MethODs
Recruitment
The study was approved by the NHS Ethics Committee (REC 
reference: 14/LO/1872), and the NHS Cambridgeshire 
and Peterborough Clinical Commissioning Group 
(CCG), before any participant was approached. Primary 
care practices within the CCG, with the highest recorded 
numbers of patients with hypertension and T2DM, and at 
different levels of deprivation, were eligible for this study. 
Sixty-one practices were invited by the research team, and 
five of them participated in the study, of which four had 
list sizes smaller than the average, and one larger than 
the average, when compared to other practices within 
the CCG. The practices varied in deprivation level. Three 
practices invited nurses, and four invited patients, to take 
part in the study.
Nurses eligible for inclusion were those who were 
involved in advising, encouraging, or supporting patients 
to adhere to their treatments. Eligible nurses were 
approached face-to-face by the practice manager, given 
the study information pack, and invited into the study. 
Five nurses, from three practices, provided written 
informed consent, and took part in the interview. Patients 
eligible for inclusion were those: (a) aged 40 and over; 
(b) with a primary diagnosis of hypertension and/or 
T2DM; (c) who were non-adherent to their medication 
regimens, as indicated by clinical measures closest to 
the last refilled medication prescription, or with gaps in 
ordering or refilling repeat prescriptions during the last 
three months; and (d) had visited the practice at least 
once during the last six months.
The practice manager selected eligible patients from 
the practice database. A GP screened the list of eligible 
patients for the main exclusion criteria (e.g., recent 
acute health event; diagnosis of dementia, aphasia, or 
other cognitive difficulties; severely impaired hearing or 
speaking). Practice staff posted study invitation packs to 
those selected for inclusion. In total, 150 invitations were 
sent to eligible patients, and 19 expressed an interest, and 
provided written informed consent to participate in the 
study. The recruitment was completed when saturation of 
the data had been achieved.15 The study  recruited less 
nurses than stated in the protocol, because the collected 
data had reached saturation, after implementing constant 
comparisons between themes.
Interviews
At baseline, face-to-face interviews were conducted using 
a semi-structured guide to identify the reasons for non-ad-
herence. The interview guide was informed by a review 
of evidence and theory-based research.16 17 The theoret-
ical concepts that best explained medication adherence 
change, were mapped onto interview questions, and 
informed the interview schedule (see online supple-
mentary files 1 and 2). Interview prompts facilitated the 
in-depth exploration of meanings and the identification 
of themes.18 We asked nurses their views on: (a) patients’ 
experiences with taking medicines, and barriers to adher-
ence; (b) their current actions to address non-adherence; 
and (c) their recommendations about the development of 
a telephone-based intervention, as an adjunct to primary 
care. Interviews with nurses were conducted from January 
2015 until April 2015. We asked patients about their views 
on: (a) their condition; (b) medication adherence; (c) 
barriers and facilitators in taking their medicines; and 
(d) whether, and how, an automated telephone-based 
intervention could support them take their medications 
as prescribed. Baseline interviews with patients were 
conducted from July 2015 untill September 2015.
Based on the baseline interviews, an IVR platform to 
deliver the intervention messages was developed.9 The 
content of the IVR messages was developed by combining 
the findings from the baseline interviews and systematic 
literature reviews, which explored the effective behaviour 
change techniques (BCTs) to support medication adher-
ence.10 11 19 At the follow-up interviews, a think-aloud 
protocol to gain participants’ experiential feedback on 
elements of the IVR was used. Participants were asked to 
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trigger and complete one or two IVR calls, and verbalise 
their thoughts during and after the calls. Each IVR call 
lasted approximately 1–5 min. Participants were asked 
and prompted to think aloud their views on the delivery 
mode, and the content of the messages;and asked their 
recommendations on how the IVR messages could be 
improved, and support them to adhere to their medi-
cations best. Follow-up interviews with patients were 
conducted from March 2016 until April 2016.
The first author constructed the interview guide, think-
aloud protocol, IVR messages, and conducted interviews 
and analysis, with input from the second author. The 
first author had experience and training in qualitative 
research. The second author is also a leading expert in 
the topic of research. Patients were interviewed at their 
homes (n=11 baseline and n=12 at follow-up), at the 
University (n=7 at baseline), or at their workplace (n=1 
at baseline and n=1 at follow-up). There was the inten-
tion for all the follow-up interviews to take place at 
participants’ homes, to facilitate the collection of contex-
tual information.20 All nurses were interviewed at their 
practices. All interviews were face-to-face with only the 
researcher and the interviewee present, apart from one 
baseline interview, where the interviewee’s partner was 
present to assist with translation. Each baseline interview 
lasted on average one hour, and each follow-up interview 
30 minutes. All interviews were digitally recorded, and 
transcribed by an independent service. Transcripts were 
double-checked against audio recording and field notes 
for accuracy,by the researcher.
Analysis
The data collected from the two cross-sectional sets 
of interviews (i.e, baseline interview with patients and 
nurses) were analysed using in-depth, multiperspective, 
thematic analysis.21 All interviews were analysed separately. 
After that, data were integrated into broader descriptive 
categories. For baseline interviews, latent themes from 
patients and nurses’ interviews were identified induc-
tively and synthesised into one analysis, capturing both 
perspectives. Themes from the follow-up interviews were 
mapped onto those from baseline interviews, and any new 
themes (e.g., on acceptability of the IVR delivery mode) 
were treated separately.22
results
Participants
In total, 37 interviews were conducted: 19 patients were 
interviewed at baseline, 13 of whom were interviewed few 
months later; and 5 nurses. Patients’ mean age at baseline 
was 62.3 years, seven of them were female, 13 reported a 
primary diagnosis of hypertension, three reported T2DM, 
and the rest reported diagnosis of comorbidities of 
cardiovascular conditions (e.g., stroke) and T2DM. More 
information about the practices,nurses, and patients’ 
characteristics can be found in table 1.
reasons for medication non-adherence
Participants reported that they do not initiate taking their 
medications as prescribed, when they do not understand 
the need to take medicines to support them manage their 
long-term health conditions.
“I think probably they don’t think they need them, to be 
honest with you. ‘I don’t need them what are you giving me 
these for?’ yeah ‘I’m well, look at me, I’ve been like this all me 
life’.” Patient B2
‘The trouble with diabetes is people don’t realise that 
they’ve got it, and they go on for a couple of years before it’s 
discovered, and they probably have gone all this time and 
not felt ill at all; and then they’ve been given a tablet, so 
they haven't really had a time when they felt ill.’ Patient 
B4
“I suppose, deep down they are not really happy to be taking 
medication, and they think if they ignore the problem then, or 
they keep the tablets on the side ,and they think ‘oh I’ll take 
it, if I really need it’.” Nurse A5
Some participants reported that they intentionally 
changed or stopped the course of their medications, 
when they had no health benefits by taking them. The 
underlying affective state, associated with taking medi-
cations, was important to mobilise sustained adherence. 
Participants, who reported not feeling any different by 
taking medications, seemed to report low motivation to 
adhere to their prescriptions.
‘He say that he takes one tablet one day, two tablets, second 
tablet second day, and it helps, but after, for example, 
the second tablet on the fourth day it doen't help any 
more ….[he became] accustomed with this tablet, with the 
medications [and don’t want to take more]. He went more 
times to the GP and they gave him the same. The tablets did 
nothing.’ Patient B17
‘I don’t really ever consider that I’ve got high blood pressure. 
I just don’t think about it… with blood pressure it’s just how 
I feel, I don’t know what it feels like. It is, like, say, there's 
nothing really to tell me day-to-day.’ Patient B14
‘I often think all these six going down my throat ,all in one 
go, and they’re all releasing their selves, but I don’t feel any 
different no…You don’t realise what these tiny little things 
have got in them do you?’ Patient B4
‘If they’re feeling well, they’ll drop it out or, drop down… 
they think they don’t need it. They just don’t want to take 
something every day.’ Nurse A4
Participants, who had unpleasant side effects from 
taking medications, reported stopping or skipping their 
tablets.
‘The side effects there were which made me feel ill, there’s no 
point in taking pills that make you feel ill, is there?’ Patient 
B2
‘I felt as though I was walking through treacle, I wasn’t right 
at all, so no, we don’t take that one anymore.’ Patient B10
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Table 1 Practice and participants’ characteristics.
Practice
Deprivation level within CCG, 
area, practice list size on average 
within CCG, patient/doctor ratio, 
patient/staff ratio (excluding 
doctors)
Participants
Nurses’ 
pseudonyms 
and gender
Patients
Pseudonyms Age Gender Primary diagnosis
Participated 
at follow-up 
interview*
Average deprived; urban; small; 
1136.6/1; 516.6/1
A1 female B1 80 Male T2DM and 
hypertension
Yes
B2 70 Male Hypertension and 
stroke
Yes
B3 67 Male Hypertension Yes
B4 70 Female T2DM Not interested
B5 66 Male Hypertension Not interested
B6 71 Female Hypertension Yes
Least deprived; rural; small; 1208/1; 
302/1
A3 female B7 57 Female Hypertension Moved area
A4 female B8 61 Female Hypertension Yes
Less deprived; rural; large; 
1275.37/1; 351.8/1
B9 51 Female Hypertension Yes
B10 64 Female Hypertension Yes
B11 70 Male Hypertension and 
T2DM
Yes
B12 64 Male Hypertension Yes
B13 65 Male Hypertension Yes
B14 44 Male Hypertension No time
B15 52 Male Hypertension Yes
B16 61 Male Hypertension and 
T2DM
Yes
Most deprived; urban; small; 
702.6/1; 301/1
A2 female B17 45 Male Hypertension Excluded
B18 50 Female T2DM Yes
Least deprived; rural; small; 1378/1; 
393.8/1
A5 female B19 77 Male T2DM No time
Participants’ 
mean age in 
years
62.3
Average list size: CCG n=933,265 of whom n=117,784 patients with hypertension and n=43,296 with diabetes.
Note. CCG, Clinical Commissioning Group; A(x) letter code to anonymise nurses (number code to anonymise nurses); B(y) letter code to 
anonymise patients (number code to anonymise patients); T2DM, type 2 diabetes mellitus;*Yes, if participants took part in the interviews; or 
reported reasons for not taking part.
, ; .
‘I’ll come across people, who won't take something the doctor 
has prescribed, because they’re getting side effects that they 
don’t like. For example, Metformin which gives them tummy 
ache, and the doctor might have prescribed say, two, or three 
doses a day, and they’ll only take one…generally speaking, 
Metformin in the first couple of weeks can cause a lot of 
indigestion, nausea, tummy aches, that kind of thing,and 
often patients don’t like it, so they stop taking it.’ Nurse A5
The regimens people were prescribed were also 
mentioned as an important barrier for medication 
non-adherence. People taking lots of pills reported 
limited ability to cope with multiple regimens, and those 
taking few pills reported lack of motivation to continue 
taking their tablets as prescribed.
“Sometimes I think it’s that they, they’ve got so much 
medication, they say ‘I've got so much medication, I forget’.” 
Nurse A3
“If I'm routinely asked to take a pill without really knowing 
why I’m taking it, it’s not a very good incentive to take that 
pill…they may walk out of this surgery thinking ‘do I really 
need to take this [medication]?’, I lose the prescription or not 
quite make it to the chemist.” Patient B13
Some participants reported beliefs that behaviours 
can have an accumulative or counteractive effect to each 
other. In these cases, participants tended to alter their 
dosages according to the other behaviours, enacted at 
times and/or places, related to their mediation taking 
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behaviour. For example, people reported that they 
intentionally alter, or miss, their tablets when socialising, 
especially when their social environment did not support 
them taking their medications.
‘The only time I don’t take it, if I go to a birthday party, or 
wedding, or whatever, where you abuse yourself with a bit too 
much alcohol. I think I’d rather not take the tablets, because 
I don’t want it interfering with the alcohol in me, there’s 
enough poison in there as it is.’ Patient B11
‘Yeah, I won’t take it if I’m out. If we go out for dinner, I 
won’t take my tablets, because I don’t want other people to see 
me taking them.’ Patient B18
Some participants also reported difficulties in taking 
their medicines, when they change their everyday routine 
and/or they are busy. For example, one participant 
reported forgetting taking his pills, when going away for 
the weekend; whereas another reported forgetting, when 
he has multiple activities to do in a day. Additionally, 
nurses reported participants’ memory issues as a reason 
for NINA.
‘I just take them when I get up, and if I get up in a rush, 
then that is when I can forget. 'I will take the cardinipine 
later in the day', but I’ve forgotten after about lunchtime.’ 
Patient B8
‘Oh well I got down to me daughter’s in Kent once, when 
was that? Not last Christmas, the Christmas before, and I’d 
forgotten. I’d taken most of me pills but I’d forgotten half of 
them, so we had to go round to the local doctors and get a 
prescription, luckily I’d got a copy of my prescription what I 
take.’ Patient B1
‘Memory problems, so we would see maybe forgetfulness, 
living on their own, nobody to prompt them.’ Nurse A1
‘I came across a patient the other day who admitted that he 
took it when he remembered, and that was possibly two, three 
times a week.’ Nurse A5
current actions to promote medication adherence and 
recommendations for an intervention
Participants reported that one way to remember to take 
their medications as prescribed was to add reminders to 
their environment. These cues were already associated 
with activities of their daily routine, and were enacted at 
close time and space proximity with taking medications.
‘[In the morning] I have a coffee, I put the mug of milk 
[for the coffee] in the microwave…before I go to bed, I put 
the pills in the microwave…to make me remember and get 
into the habit of it, 'you don’t have your coffee until you’ve 
had your medication, otherwise you don’t have a coffee'. 
You must associate that and put them together, I do and it 
works.’ Patient B3
‘I suppose it’s quite a little routine isn’t it? I actually put a 
handkerchief by the bed, so that I wake up, either when the 
alarm goes, or usually I wake up half an hour or so before the 
alarm,and I find it and take it with a shot of water, I have 
a bottle of water by the bed.’ Patient B5
‘I think it’s about patterns in my life, so every morning I 
have a tray, that’s where my phone, my keys are, everything 
I need for the next day I put on that tray…so every morning 
I’d put that [tablet] on my little tray, so really just finding 
somewhere every day where I’ve got the things that I need for 
the next day has been a help to me. Because when I did not 
have that pattern, I’d go to work and ‘oh I need my pill now, 
it’s at home.’ Patient B14
Patients were satisfied with the current practices in 
primary care, in terms of providing them with advice on 
how to take their medications. Some nurses also reported 
that they encourage patients to add cues to their envi-
ronment, to help them cope with forgetfulness. Another 
nurse reported that she advises patients, about how to 
cope with their underlying affective state during the 
course of their medications.
“Just a lot of encouragement, there was a lot of contact, and 
checking ‘have you done this’ and ‘did you do that’ or ‘well 
done you’, trying to give them a bit of a boost. I think that’s 
about the best you can do.” Patient B10
“I said to her ‘would you go out the house without cleaning 
your teeth’, ‘no’, ‘so put it by your toothbrush’.” Nurse A1
‘The other thing I tell them is that 'how you think you feel 
is often not a good indication of actually what state you are 
in, because you just get used to feeling in a certain way'.’ 
Nurse A3
However, both patients and nurses reported challenges 
with the time available within a consultation to address 
each patient’s needs regarding their medications. More-
over, participants reported challenges with their abilities 
to support themselves (in the case of patients), or provide 
support to patients (in the case of nurses), to adhere to 
prescriptions daily, and/or during conflicting conditions.
‘I think, if you’ve been advised to take it, and you don’t, what 
can they do? I don’t see what help they can do.’ Patient B6
‘I had a new patient’s appointment on Tuesday afternoon, 
and she’s got a list of things that she’s got to do, she’s got to 
go through what medication you're on, she’s got to test your 
urine, she’s got to take your blood pressure, and ask these 
questions, and she’s got 10 min to do it.’ Patient B9
“Yeah on the prescriptions it will say ‘take one tablet daily or 
every day’… people don’t want to sit and read it.” Nurse 
A1
“They don’t actually understand how the stuff works in the 
first place so but, but I know that I've had patients back 
who are saying ‘I didn’t know that’ and I know that I told 
them two years ago, because it’s documented in their notes, 
so they don’t always listen either, that’s the other thing… 
But we really haven't got time to be going into everybody’s 
medications, and why, and how they take them, I just think 
you can't go round people’s houses and ram their pills down 
their throat twice a day, can you?.” Nurse A4
“Sometimes patients say things to you and then you find out, 
when you actually check their medications or prescriptions, 
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that they’re not doing what you asked them to do really. . 
and I suppose there's always this feeling of ‘I’ll do something 
about it’, very motivated when they leave the surgery, ‘I’ll 
sort it out, I am nogoing to have medicines, I’m going to sort 
this problem out’ but actually when it comes to it, it’s very 
difficult to change some lifestyle.” Nurse A5
Both nurses and patients expressed favourable views 
on an automated, telephone-based intervention; and 
suggested that such an intervention could be more effec-
tive, if it was tailored to each patient’s reasons for not 
taking medicines as prescribed.
‘If it was set automatically, that would be brilliant… as 
long as it was automatic and didn’t cost any money, for the 
health service, not just me.’ Patient B8
‘It’s like there's not a pill that will sort everyone out. It’s 
a very complicated thing, you really need to fit the answer 
to the person, so you need to find out from them… in 
order to get someone to take their medication you’ve got to 
understand how they fit their world together…so, if someone 
doesn’t establish routines, you’ve got to find out how they’re 
keeping their life together.’ Patient B5
‘One size doesn’t fit all really does it? Everybody’s different 
and what works for one person doesn’t always work for 
another…ask them what they would prefer, I think that 
could be good.’ Patient B9
‘I think it would need to be different for different people, I 
don’t think you could do that across the board.’ Nurse A5
Acceptability of the IVr delivery mode
IVR seemed to be an acceptable platform to deliver 
messages for medication adherencefrom the majority of 
the participants. Specifically, participants liked the voice 
delivering the call, the navigation options, and the voice 
recognition software. Even one person, who was reluctant 
about the automatic element of the call, reported that 
receiving an automated call would have been better than 
forgetting medications.
‘Now that you’ve told me it’s not a person I’m talking to, I 
can say what I like, can't I? A lot of people when they pick 
up that phone are going to think they are talking to a real 
person. They’re not. It’s a nice, it’s well pitched, the lady 
is a pleasant voiced lady, it doesn’t sound like a cold call 
or anything…[voice recognition] it’s better than pressing 
buttons, I hate pressing buttons it’s awful.’ Patient B13
“I don’t know how to explain it, but to be actual talk to 
a person than a machine is entirely different …that might 
put certain people off, but on the other hand, it might 
think ‘thank goodness that came through, I’ll take my 
medication’.’’ Patient B6
‘So many firms if you press this and you press that, press one, 
press two, press three. I: Would you prefer that, or would you 
prefer to speak to (an automated voice response system) R: 
Yeah this is better, that’s much better.’ Patient B8
Participants seemed to also like the interactive element 
of the IVR delivery mode, which they used to report 
missing some of their dosages, and/or to ask for advice 
on how to cope with non-adherence.
“If you’ve got something wrong with you, then you probably 
wait a few months to go to the doctors…or ’ll think ‘oh I 
can get over this’ and so on, but really in the background in 
their mind they are slightly worried and they might want a 
bit more information. I: So do you think they would do that 
through that system? R: I think they would, as a starting 
point, because it’s not going, it’s not talking on a one-to-one 
with somebody, you're actually just accessing an accurate 
database which is reliable.” Patient B16
‘I did forget to take my tablets this morning, can I still take 
them now or should I just wait for the next day?’ Patient 
B18 inbound call
“if I ring up now and say ‘oh my prescription’s run out can 
I order a new prescription?’” Patient B12
Acceptability of the intervention content
Most participants expressed favourable views about the 
content of voice messages, which included BCTs, to 
address reasons for non-adherence. Specifically, they 
found useful the messages that included ‘information 
about the health consequences’ of adhering, or not, to 
their medicines, especially since hypertension and/or 
T2DM can be asymptomatic. Specifically, participants 
highlighted the importance of messages that reminded 
them of the reasons they need to take their medicines as 
prescribed. Participants reported that receiving messages 
at occasions, which they usually find challenging to 
adhere to their medications, could support them take 
their tablets as prescribed.
‘R: people get it into their heads that they feel alright and 
therefore they don’t need to take it. I thought it was good in 
the message that you said that they need to take it regularly 
in order to maintain, to keep their blood pressure down.’
‘I: do you think this information is not known to people?’
‘R: maybe they choose to ignore it. They probably do, but high 
blood pressure is one of those things that unless you actually 
feel it you're not aware that it’s a problem.’ Patient B9
Additionally, most participants liked simple messages 
that prompted them to take their medications at a due 
time, and facilitated conscious thinking of their behav-
iour.
“‘Hello Mrs, have you taken your drugs today?’ just to 
remind them.” Patient B2
“I'm thinking if they ring up, it’s like some of my medication, 
like the warfarin, I have to take it at a certain time, if I don’t 
take it then I've basically got to wait 24 hours and take the 
next. If it says ‘have you taken your medication?’ you say 
‘no’ then that comes across and say ‘oh best I’d take it’.” 
Patient B12
“I got a call at midday saying ‘have you taken your 
medications today?’…it would cause me to think before I 
answered [laughs].” Patient B16
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However, messages that included information about 
the duration of their health condition, rather than infor-
mation about how to support themselves to adhere to 
their medications; and messages that asked them to put 
effort in self-monitoring their medication taking behav-
iour (e.g., keeping a diary every day) seemed not to be 
acceptable.
“It’s saying to me, 'you’ve been taking this medication for 
seven years'. I don’t need them to tell me why, like I know 
really, I just need reminding to take it. The other thing is, it 
says about writing down in your diary, but if I was getting 
the calls I would be like ‘what are you talking about?’ do 
you know what I mean? I wouldn’t want to be told to write 
it down. I think if I was that organised that I would write 
down in a diary, I wouldn’t need somebody to ring me. I 
literally would just want it to say ‘take your medicine’.’’ 
Patient B18
Personalised voice messages (i.e., that included 
patients’ names) seemed to be acceptable to the majority 
of the participants.
‘I think they will because it says your name, so you're waiting 
for it.’ Patient B18
‘It feels like somebody who’s closer to you, somebody’s who’s 
on, familiar with you, so in that respect it’s better.’ Patient 
B9
DIscussIOn
Principal findings
Beliefs about the need to take medications, the number 
of prescribed doses, and the ability to cope with the 
underlying affective state, within challenging contexts, 
were mentioned as important reasons for adherence 
to cardiometabolic medications. Nurses reported time 
constraints to address each patient’s different reasons 
for non-adherence, and limited efficacy to support them 
between, and sometimes during, the primary care consul-
tations. Both patients and nurses had favourable views 
on an automated, telephone-based intervention, and 
recommended messages to be tailored to each patient’s 
needs for taking medications. Patients expressed positive 
experiential feedback about elements of the IVR, and 
provided recommendations for intervention content 
and delivery mode. Specifically, participants liked the 
voice delivering the messages and the voice recognition 
software. For intervention content, patients expressed a 
preference for messages that are tailored to their condi-
tions, include ‘information about health consequences’, 
or simple reminders of the behaviour. The interactive 
element of the interventions seemed to be most useful 
for people to request support, when they had missed 
their tablets. Including elements of personalisation 
would increase uptake and initial engagement with the 
intervention.
strengths and limitations
This study invited patients whose practice records 
suggested that they were not refilling their prescrip-
tions and/or not managing their blood pressure or 
glucose levels. Insights obtained from these patients can 
usefully inform the content, and delivery, of a medication 
adherence intervention within primary care. However, 
consideration should be given when translating these 
results to different populations (e.g., patients who do not 
attend practices or those not participating in research), 
and other settings (e.g., community).
comparison with existing literature
Previous studies have investigated the reasons for medica-
tion non-adherence,23 as well as patients or practitioners’ 
views of an intervention to address non-adherence.24 25 In 
line with previous research, participants’ attitudes about 
the need to take medications, especially when they are 
prescribed complex medication regimens,26 seem to be 
important reason for non-adherence. Similarly, previous 
intervention development, and feasibility, studies 
suggested that automated, telephone-based interventions 
should remind people about their prescription plan, 
provide patients with the options of interactive commu-
nication, and tailored intervention content.27 28 However, 
none of these studies had investigated the underlying 
reasons that influence non-adherence to cardiometabolic 
medications (i.e., underlying affective state); whether, 
and how, current practices address these reasons; or 
considered multiple views and recommendations on 
intervention delivery mode and content to support adher-
ence. Most importantly, none of the previous studies have 
investigated the acceptability of the IVR to address the 
reasons of non-adherence in the UK primary care setting, 
which is an important element when developing novel 
interventions.29
Implications for research and practice
IVR seems to be an acceptable mode to influence the 
determinants of medication non-adherence in patients 
with hypertension and/or T2DM. This study suggests 
that within the time constraints, and limited resources 
of the primary care, practitioners could briefly assess 
patients’ beliefs about taking medications, ability to cope 
within challenging conditions, and the complexity of 
prescriptions; and then signpost them to an IVR adher-
ence intervention. The results of this study also suggest 
that reminders of the behaviour, and ‘information about 
health consequences,’ are acceptable techniques to 
address reasons for non-adherence.
unanswered questions and future research
Future studies aiming to develop such interventions in 
primary care could usefully tailor the intervention to each 
patient’s INA and NINA reasons. Future studies could 
include effective and acceptable BCTs to address these 
reasonsand promote adherence. Future studies could 
integrate participants’ views on barriers and facilitators 
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to uptake, retention, and engagement, with such inter-
ventions. Participants’ views and recommendations on 
the delivery mode, such as the clarity, tone, volume, 
intensity, speed rate, rhythm, and vocal expression of the 
messages; the navigation options; and the frequency and 
duration of the calls, should be further explored. Addi-
tionally, future studies could explore participants’ views, 
satisfaction, mastery, and actions upon the content of IVR 
interventions; and obtain recommendations for improve-
ment. Future studies could also explore whether these, 
or additional components proposed by theories such the 
COM-B model, could impact on medication adherence,30 
using rigorous designs.
contributors AK and SS designed the study. AK conducted all tasks involved in 
completing this study, with substantial input from SS.
Funding This report is independent research by the National Institute for Health 
Research. The views expressed in this publication are those of the author(s) and 
not necessarily those of the NHS, the National Institute for Health Research or the 
Department of Health. 
Disclaimer This report is independent research by the National Institute for Health 
Research. The views expressed in this publication are those of the author(s) and 
not necessarily those of the NHS, the National Institute for Health Research or the 
Department of Health.
competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Documents describing the process of data analysis are 
available by request to the first author.
Open Access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerences
 1. Nunes V,, Neilson J, O' Flynn N. Clinical guidelines and evidence 
review for medicines adherence: involving patients decisions 
about prescribed medicines and supporting adherence. London: 
National Collaboration for Primary Care Royal College of General 
Practitioners, 2009:1–364.
 2. Sebate EWorld Health Organization.Adherence to long-term 
therapies: evidence for action. Geneva.
 3. Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular 
therapy: a meta-analysis of prevalence and clinical consequences. 
Eur Heart J 2013;34:2940–8.
 4.  Department of Health. Improving the use of medicines for better 
outcomes and reduced waste. An action plan. 2012.
 5. Bailey JE, Wan JY, Tang J, et al. Antihypertensive medication 
adherence, ambulatory visits, and risk of stroke and death. J Gen 
Intern Med 2010;25:495–503 https ://w ww.s co pus .c om/inward/re 
cord.uri?e id= 2-s2 .0-7 7955 0901 86&p artn erID =40&md 5= da6c 70e0 
b10b69d 3deedf7ee916c6165.
 6. Barber N. Should we consider non-compliance a medical error? Qual 
Saf Health Care 2002;11:81–4.
 7. Marshall IJ, Wolfe CD, McKevitt C, et al. Lay perspectives on 
hypertension and drug adherence: systematic review of qualitative 
research. BMJ 2012;345:e3953 http://www. bmj. com/ cgi/ doi/.
 8. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for 
enhancing medication adherence. Cochrane Database Syst Rev 
2014;11:CD000011.
 9. Kassavou A, Sutton S . Supporting medication adherence using 
Interactive Voice response (IVR): development and delivery of a 
theory and evidence based intervention. Eur Heal Psychol 2016;18.
 10. Tsoli S. Interactive Voice response interventions targeting behaviour 
change: a systematic literature review with meta-analysis. MPhil 
thesis dissertation, Cambridge University, UK 2015.
 11. Kassavou A, Sutton S. Automated telecommunication interventions 
to promote adherence to cardiovascular medications: meta 
analysis of effectiveness and meta-regression of behaviour change 
tehcniques. under review at Heal Psychol Rev 2017.
 12.  Statistica. Number of mobile voice call minutes in the United 
Kingdom (UK) from 2007 to 2015 (in billion minutes). 2016.
 13.  Statistica. Number of fixed voice call minutes in the United Kingdom 
(UK) from 2007 to 2015 (in billion minutes). 2016.
 14. Smith DH, O'Keeffe-Rosetti M, Owen-Smith AA, et al. Improving 
adherence to cardiovascular therapies: an economic evaluation of a 
randomized pragmatic trial. Value Health 2016;19:176–84.
 15. Chamberlain K, Camin P, Yardley L. Qualitative analysis of 
experience: grounded theory and case studies. In: Marks D, Yardley 
L, eds. Research methods for clinical and Health Psychology. 
London: sage publications, 2004.
 16. Sutton S. Stage Theories. in  Norman M eds. Predicting and 
changing health behaviour: research and practice with social 
cognition models. Buckingham: Open University Press, 2015.
 17. Farmer A, Hardeman W, Hughes D, et al. An explanatory randomised 
controlled trial of a nurse-led, consultation-based intervention 
to support patients with adherence to taking glucose lowering 
medication for type 2 diabetes. BMC Fam Pract 2012;13:30 http:// 
bmcfampract. biomedcentral. com/ articles/.
 18. Kassavou A, Sutton S What factors influence medication adherence 
in people with long term conditions, and how can these inform an 
intervention to support adherence to medications in the primary 
care setting? a longitudinal qualitative research project: a research 
protocol Cambridge University Cambridge 2014 .
 19. Kassavou A, Sutton SDeveloping and pre-testing a tailored 
interactive voice response (IVR) intervention to support adherence 
to anti-hypertensive medications: a research protocol Cambridge 
University Cambridge2016.
 20. Kassavou A, French DP, Chamberlain K. How do environmental 
factors influence walking in groups? A walk-along study. J Health 
Psychol 2015;20:1328–39 http:// journals. sagepub. com/ doi/.
 21. Kendall M, Murray SA, Carduff E, et al. Use of multiperspective 
qualitative interviews to understand patients' and carers' beliefs, 
experiences, and needs. BMJ 2009;339:b4122http://www. bmj. com/ 
cgi/ doi/.
 22. Kassavou A, Turner A, French DP. The role of walkers' needs and 
expectations in supporting maintenance of attendance at walking 
groups: a longitudinal multi-perspective study of walkers and walk 
group leaders. PLoS One 2015;10:e0118754.
 23. De Simoni A, Mant J, Sutton S. Adherence to medication in 
stroke survivors dependent on caregivers. Br J Gen Pract 
2015;65:e789–e791.
 24. Lecouturier J, Cunningham B, Campbell D, et al. Medication 
compliance aids: a qualitative study of users' views. Br J Gen Pract 
2011;61:93–100.
 25. Nolan T, Dack C, Pal K, et al. Patient reactions to a web-based 
cardiovascular risk calculator in type 2 diabetes: a qualitative study 
in primary care. Br J Gen Pract 2015;65:e152–e160.
 26. Jamison J, Graffy J, Mullis R, et al. Stroke survivors', caregivers' 
and GPs' attitudes towards a polypill for the secondary prevention 
of stroke: a qualitative interview study. BMJ Open 2016;6:e010458 
http:// bmjopen. bmj. com/ lookup/ doi/.
 27. Rana Y, Haberer J, Huang H, et al. Short message service (SMS)-
based intervention to improve treatment adherence among 
HIV-positive youth in Uganda: focus group findings. PLoS One 
2015;10:e0125187.
 28. Osborn CY, Mulvaney SA. Development and feasibility of a text 
messaging and interactive voice response intervention for low-
income, diverse adults with type 2 diabetes mellitus. J Diabetes Sci 
Technol 2013;7:612–22 http:// ovidsp. ovid. com/ ovidweb. cgi? T= JS& 
PAGE= reference& D= emed11& NEWS= N& AN= 23759393.
 29. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating 
complex interventions: the New Medical Research Council guidance. 
BMJ 2008;337:a1655–a1655. http:// discovery. ucl. ac. uk/ 103060/% 
5Cnhttp:// www. bmj. com/ cgi/ doi/.
 30. Eliasson L, Barber N, Weinman J, et al. Applying COM-B to 
medication adherence: a suggested framework for research and 
interventions. Eur Heal Psychol 2014:7–17.
